PATENT CLAIM ANALYSIS

Application Number: 15876525
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-06
Patent Classification: ["546", "208000"]

Abstract:
This invention provides compounds of formula I: wherein a, b, c, d, m, n, p, s, t, W, Ar 1 , R 1 , R 2 , R 3 , R 4 , R 6 , R 7 , and R 8  are as defined in the specification. The compounds of formula I are muscarinic receptor antagonists. The invention also provides pharmaceutical compositions containing such compounds, processes and intermediates for preparing such compounds and methods of using such compounds to treat pulmonary disorders.

Claim (Index 35):
The method of  claim 33 , wherein the pharmaceutical composition further comprises a buffer.

Metadata:
- Claim Count in Document: 84.0
- Percentile: 86.0
- Lexical Diversity: 1.75
- Patent Class: 546.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14539550', '13438105', '11880007', '11077433', '12437766']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8760490824277467
- 35 USC 102 Novelty (BERT): 0.5610917465212748
- Combined Prediction Score: 0.8445533488370995
- Mean Citation Score: 475.86484600000006
- Max Citation Score: 502.89685
- Similarity Product: 331.3697466041893

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test